PUMA Welcomes Athletes to Budapest Ahead of World Athletics Championships
19.8.2023 13:48:00 EEST | Business Wire | Press release
Sports company PUMA has kicked off its celebrations for the World Athletics Championships in style, welcoming athletes and media from around the world to the official opening of the PUMA House.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230819043891/en/
Sports company PUMA has kicked off its celebrations for the World Athletics Championships in style, welcoming athletes, and media from around the world to the official opening of the PUMA House. Maria Valdes (Chief Product Officer at PUMA) and Erin Longin (General Manager, Run/Train) took to the stage alongside PUMA ambassadors, and icons of track and field including Karsten Warholm, Marcell Jacobs, Julien Alfred, Mutaz Barshim and Pia Skrzyszowska, giving insight on their preparations and expectations for the competition. Guests were also given the opportunity to hear from Jamaican athletes Shericka Jackson, Rasheed Broadbell, Hansle Parchment, and rising star Jaydon Hibbert. Watch the highlights video on PUMA YouTube. (Photo: Business Wire)
Maria Valdes (Chief Product Officer at PUMA) and Erin Longin (General Manager, Run/Train) took to the stage alongside PUMA ambassadors, and icons of track and field including Karsten Warholm, Marcell Jacobs, Julien Alfred, Mutaz Barshim and Pia Skrzyszowska, giving insight on their preparations and expectations for the competition.
Maria Valdes said: “2023 is a great year for us - it’s our 75th year anniversary – and we truly believe that track and field is the root of many sports. There are so many memorable moments we can look back on where track and field really represented our brand. From Tommie Smith back in 1968 to the numerous world records of Bolt just a couple of years ago. We hope to have more moments like this that can help shape us for years to come – starting here in Budapest.”
Karsten Warholm said: “Confidence is something you build. Obviously, it's not a given. If it is, it's not real. We prepare very well in training, and I think that is the secret to my confidence. My coach takes good care of me and the way we work, we always have control. And then of course when you go to a World Championship, you never know what you can pull out of the hat.”
Marcell Jacobs said: “Maybe I had too many injuries in the last two years… I really tried to overcome all of those problems. I'm the one who wants to be in a good shape, perfectly fit, and ready to face this very important challenge at the World Championships in Budapest.“
Julien Alfred said: “It's been fantastic to be part of the Puma family. Puma is a great brand who have paved the way for many of my idols and it feels great. And I really love the spikes as well!“
Guests were also given the opportunity to hear from Jamaican athletes Shericka Jackson, Rasheed Broadbell, Hansle Parchment, and rising star Jaydon Hibbert.
Shericka Jackson said: “I've been working hard and there is no pressure for me. I'm in good shape and I'm going to show up, stay in my lane and focus on me.“
Rasheed Broadbell said: “It's really not a bad feeling [to not be the favourite], but a good thing, because the attention is not on me, so it's not really much pressure… But whoever the eyes is on, they have to ensure that they deliver. So for me, it's just keeping in my lane, stay focused and deliver.“
Hansle Parchment said: “Usually everybody is going to the US for college, but at the last minute we changed our minds to go to the University of the West Indies. I think that was a very good decision for me, otherwise I would have been running every weekend in the US. I'm very happy that I made that decision to stay in Jamaica.”
The World Athletics Championship Budapest 2023 will take place from 19-27 August.
Video:
To watch the full press conference – click here
To download the full press conference – click here
To watch the highlight video – click here
Images:
PUMA House imagery – click here
PUMA
PUMA is one of the world’s leading sports brands, designing, developing, selling and marketing footwear, apparel and accessories. For 75 years, PUMA has relentlessly pushed sport and culture forward by creating fast products for the world’s fastest athletes. PUMA offers performance and sport-inspired lifestyle products in categories such as Football, Running and Training, Basketball, Golf, and Motorsports. It collaborates with renowned designers and brands to bring sport influences into street culture and fashion. The PUMA Group owns the brands PUMA, Cobra Golf and stichd. The company distributes its products in more than 120 countries, employs about 20,000 people worldwide, and is headquartered in Herzogenaurach/Germany.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230819043891/en/
Contact information
Media Contact: Stefan.Popovic@Puma.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Doubtless Pet Care Launches to Provide Peace of Mind to Pet Parents and Help Their Pets Live Happier, Healthier Lives29.6.2026 11:15:00 EEST | Press release
Doubtless launches today with the goal of helping more pet parents across the world access quality care for the pets they love. The company brings together a leading global portfolio of pet insurance brands with a growing range of connected solutions designed to support pet parents at every stage of their pet’s life. With over 4,000 employees, Doubtless insures 6 million pets across 10 markets in North America, Europe and the United Kingdom. “Uncertainty about the financial commitments associated with having a pet should never keep families from experiencing the joy of a life with pets,” said Dirk Beeckman, CEO of Doubtless. “By harnessing the power of our international footprint, we are building on our leadership in pet insurance to create a global suite of solutions for pet parents, veterinarians and industry partners that makes pet care easier to access, navigate and manage. This will ultimately give pet parents better guidance, greater confidence and more control at every point in
Coolbrook Secures Business Finland Funding to Accelerate Electrification for the Global Steel Industry29.6.2026 11:00:00 EEST | Press release
Coolbrook, a transformational technology company dedicated to decarbonising heavy industry and industrial processes, has been awarded research and development funding by Business Finland to accelerate the decarbonisation of steel production. The grant supports Coolbrook’s participation in the FutSteel project, a core component of the Sustainable World through Steels ecosystem led by SSAB. Within the broader FutSteel project, Coolbrook’s project scope amounts to €5 million, of which €2.5 million is covered by grant funding awarded to Coolbrook. The funding will enable Coolbrook to further accelerate and develop its next-generation RotoDynamic Heater™ (RDH™) technology, specifically tailored for high-temperature steel industry applications. The project focuses on integrating RDH™ technology into critical stages of the steel production chain, including blast furnace processes, electrified reheating, hot-stove air pre-heating, hybrid-heating concepts, decarbonised Direct Reduced Iron (DRI)
Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)29.6.2026 10:19:00 EEST | Press release
Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Division at Samsung Bioepis. “We are on track to complete both Phase 1 and Phase 3 studies within this year. Leveraging our robust quality management system, we remain committed to advancing our biosimilar portfolio to broaden access to life-saving biologic medicines for patients with unmet needs.” Pembrolizumab is a humanized monoclonal antibody that acts as an immune checkpoint inhibitor by targeting and blocking the programmed cell death protein 1 (PD-1) receptor on T cells. It is used to treat vari
IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment29.6.2026 10:00:00 EEST | Press release
IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/ IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Quantum: full-stack, open-architecture superconducting systems deployed on premises, inside customers' own data centers and HPC environments, where organizations own the hardware, build internal expertise, and run quantum processors alongside their existing classical infrastructure. According to the IDC MarketScape, "For institutions building long-term quantum programs, this means the workflows and intellectual property developed on IQM hardware remain portable." The report further advises: "Consi
Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations29.6.2026 10:00:00 EEST | Press release
Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European Medicines Agency (EMA) for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/DDC inhibitor-based treatment regimens. CHMP recommendation is based on data from the Phase 3 RISE-PD trial, which compared Hopledo® with immediate release levodopa/carbidopa (LD/CD) formulation in patients with Parkinson’s disease and moderate to severe motor fluctuations. In the study, Hopledo® demonstrated a significant increase in Good ON time over immediate release LD/CD with fewer daily doses and a comparable safety profile1. Hopledo® is a first-in-class, oral, modified-release formulation of LD/CD designed for the treatment of fluctuations of Parkinson’s diseas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom